Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic

Coronavirus disease 2019 (COVID-19) is a condition caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Severe cases of COVID-19 result in acute respiratory distress syndrome and death. A detrimental, hyper-inflammatory immune response with excess release of cytokines is the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavalli, Giulio, Farina, Nicola, Campochiaro, Corrado, De Luca, Giacomo, Della-Torre, Emanuel, Tomelleri, Alessandro, Dagna, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798432/
https://www.ncbi.nlm.nih.gov/pubmed/33442386
http://dx.doi.org/10.3389/fphar.2020.598308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798432/
https://www.ncbi.nlm.nih.gov/pubmed/33442386
http://dx.doi.org/10.3389/fphar.2020.598308

Ejemplares similares